Alicia Castillo-Leon
Amsterdam, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Adjuvant Chemoradiotherapy Versus Radiotherapy Alone in Women With High-Risk Endometrial Cancer (PORTEC-3): 10-Year Clinical Outcomes and Post Hoc Analysis by Molecular Classification From a Randomized Phase 3 Trial.
Journal: Obstetrical & gynecological survey
Published: October 30, 2025
The Desert Immune Phenotype in Endometrial Carcinoma: A Distinct Subgroup With Poor Prognosis and Targetable Mutations.
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: October 21, 2025
Desert Immune Phenotype in Endometrial Carcinoma: A Distinct Subgroup With Poor Prognosis and Targetable Mutations.
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: October 21, 2025
Clinicopathological and Molecular Characterization of High Grade Endometrial Carcinomas of No Specific Molecular Profile (NSMP) Stratified by ER Status.
Journal: International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists
Published: May 28, 2025
Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): 10-year clinical outcomes and post-hoc analysis by molecular classification from a randomised phase 3 trial.
Journal: The Lancet. Oncology
Published: February 26, 2025
Pattern of recurrence of the molecular subgroups in stage I high-grade endometrial cancer.
Journal: Gynecologic oncology
Published: January 06, 2025
The prognostic potential of molecular subtypes including estrogen receptor status in endometrioid ovarian cancer.
Journal: Gynecologic oncology
Published: December 08, 2024
Neo-adjuvant pembrolizumab in stage IV high-grade serous ovarian cancer: the phase II Neo-Pembro trial.
Journal: Nature communications
Published: October 22, 2024
Clinical and Molecular Characteristics of High-Risk, Recurrent, or Metastatic Endometrial Cancer That Is Human Epidermal Growth Factor Receptor 2-Low.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: October 07, 2024
Do we more often opt for conservative management of ovarian tumors after changing the Dutch national guideline on enlarged ovaries? A nationwide cohort study.
Journal: Acta obstetricia et gynecologica Scandinavica
Published: December 03, 2023
Prognostic impact and causality of age on oncological outcomes in women with endometrial cancer: a multimethod analysis of the randomised PORTEC-1, PORTEC-2, and PORTEC-3 trials.
Journal: The Lancet. Oncology
Published: November 27, 2023
QPOLE: A Quick, Simple, and Cheap Alternative for POLE Sequencing in Endometrial Cancer by Multiplex Genotyping Quantitative Polymerase Chain Reaction.
Journal: JCO global oncology
Published: May 25, 2023
Last Updated: 09/26/2026